skip to Cookie NoticeSkip to contents

Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs

Header Skipped.

Radiology Drug Trial Business Unit

About Us

Welcome to the Brigham Health Department of Radiology Drug Trial Business Unit. We are pleased to offer contract research organizations, core-imaging labs, biopharmaceutical and biotechnology companies the full spectrum of imaging-related services in support of clinical trials and other studies.

With a team of more than 100 board-certified, sub-specialized radiologists and nearly 200 PhD's, the program provides access to the expertise and technology of a premiere academic radiology department.

What We Do

We are available to provide services to support clinical trials and other studies involving radiological imaging. Offering the expertise of world-renowned radiologists and PhDs to provide blinded reads and extensive consultative services for the benefit of your clinical trial. With over 20 years of clinical trial experience, our radiologists understand the unique needs of CROs and pharmaceutical companies, and are well equipped to handle even the most challenging of studies.

Our experienced radiologists have participated in a broad range of work, such as oncology trials, nuclear medicine imaging for metastatic disease, musculoskeletal imaging for arthritis, cardiovascular imaging for pulmonary vein and cardiac assessment, pelvic ultrasound for leiomyoma treatment and endometriosis, CT for renal calculi assessment, and MRI for liver, spleen, and kidney organ volumes in hematologic and congenital conditions.

Interested in learning more? Do you need expertise that is not listed here? Please contact us to discuss our expertise in further detail.

Examples of Assessment Criteria include:

A skilled team of radiologists with extensive oncologic and non-oncologic assessment experience.

Oncologic assessments:

  • RECIST
  • RECIST 1.1
  • iRECIST
  • mRECIST HCC
  • mRECIST mesothelioma
  • WHO
  • Lugano
  • Cheson
  • Cheson 1999 IWG-NHL
  • IWG-NHL
  • IWRC
  • RANO
  • RANO-BM
  • PCWG
  • PCWG 3

Non oncologic assessments:

  • AVN scoring
  • Bone Age
  • DXA
  • Fibrodysplasia ossificans progressiva evaluation CT
  • Haemophilic Arthropathy
  • Osteoarthritis KL scoring knees and IA scoring other joints
  • Osteochondroma detection
  • Rheumatoid arthritis scoring
  • Heterotopic ossification evaluation and measurement 
  • Kidney Volume
  • Liver Volume
  • Spleen Volume
  • Endometrial Thickness
  • Pulmonary Vein Diameter
  • Contact Us

Interested in learning more about how we can partner with you on your clinical trial? Please contact our leadership team via email at knardozza@bwh.harvard.edu or call (617) 732-5358. We are looking forward to working with you.

Raquel O. Alencar, MD, PhD

Raquel O. Alencar, MD, PhD

Radiologist, Abdominal Imaging and Interventional Radiology Section
Medical Director, Brigham Health Radiology Drug Trial Business Unit
Assistant Professor of Radiology, Harvard Medical School

Learn More 
Kathryn A. Nardozza, MHA

Kathryn A. Nardozza, MHA

Program Administrator, Brigham Health Radiology Drug Trial Business Unit
Department of Radiology
Phone: (617) 732-5358
knardozza@bwh.harvard.edu

LEARN MORE ABOUT BRIGHAM AND WOMEN’S HOSPITAL


For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.

About BWH